These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24798832)

  • 1. Rebuttal from Drs Suissa and Rabe.
    Suissa S; Rabe KF
    Chest; 2014 May; 145(5):942-3. PubMed ID: 24798832
    [No Abstract]   [Full Text] [Related]  

  • 2. Response.
    Rho J; Ho N; Prasad V
    Chest; 2015 Jul; 148(1):e31-e32. PubMed ID: 26149564
    [No Abstract]   [Full Text] [Related]  

  • 3. Roflumilast in COPD.
    Worndl E; Hunt EB; Kennedy MP; Henry MT; Plant BJ; Murphy DM
    Chest; 2015 Jul; 148(1):e31. PubMed ID: 26149563
    [No Abstract]   [Full Text] [Related]  

  • 4. Rebuttal from Dr Rho et al.
    Rho J; Ho N; Prasad V
    Chest; 2014 May; 145(5):943-4. PubMed ID: 24798833
    [No Abstract]   [Full Text] [Related]  

  • 5. Point: were industry-sponsored roflumilast trials appropriate? Yes.
    Suissa S; Rabe KF
    Chest; 2014 May; 145(5):937-9. PubMed ID: 24798830
    [No Abstract]   [Full Text] [Related]  

  • 6. Counterpoint: were industry-sponsored roflumilast trials appropriate? No.
    Rho J; Ho N; Prasad V
    Chest; 2014 May; 145(5):939-42. PubMed ID: 24798831
    [No Abstract]   [Full Text] [Related]  

  • 7. Side-effects of roflumilast.
    Gupta S
    Lancet; 2012 Feb; 379(9817):710-1; author reply 711-2. PubMed ID: 22364756
    [No Abstract]   [Full Text] [Related]  

  • 8. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
    Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
    Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapy for managing moderate to severe chronic obstructive pulmonary disease.
    Chou A; D'Urzo AD
    Can Fam Physician; 2014 Apr; 60(4):352-4. PubMed ID: 24733327
    [No Abstract]   [Full Text] [Related]  

  • 10. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
    Doggrell SA
    Expert Opin Pharmacother; 2006 Mar; 7(4):485-8. PubMed ID: 16503820
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical profile of roflumilast].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New evidence in pulmonary and preventive medicine.
    Dilaghi B; Modesti PA; Conti AA; Nozzoli C
    Intern Emerg Med; 2010 Apr; 5(2):157-9. PubMed ID: 20333483
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL
    Rev Clin Esp; 2011 Mar; 211 Suppl 2():22-30. PubMed ID: 21596170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roflumilast (Daliresp) for COPD.
    Med Lett Drugs Ther; 2011 Jul; 53(1369):59-60. PubMed ID: 21778965
    [No Abstract]   [Full Text] [Related]  

  • 16. [Roflumilast: a new approach to therapy of chronic obstructive pulmonary disease].
    Kreutzkamp B
    Med Monatsschr Pharm; 2010 Jul; 33(7):236-43. PubMed ID: 20687460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase-4 inhibition in COPD.
    O'Byrne PM; Gauvreau G
    Lancet; 2009 Aug; 374(9691):665-7. PubMed ID: 19716944
    [No Abstract]   [Full Text] [Related]  

  • 18. [Roflumilast: clinical review of a new option for the treatment of inflammation in COPD].
    Martínez FJ
    Arch Bronconeumol; 2010 Nov; 46 Suppl 9():8-11. PubMed ID: 21320811
    [No Abstract]   [Full Text] [Related]  

  • 19. Does roflumilast induce phagocytic activity in COPD patients?
    Ghosh B; Vanjare NV
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1931-4. PubMed ID: 26392768
    [No Abstract]   [Full Text] [Related]  

  • 20. Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far.
    Giembycz MA
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):48-64. PubMed ID: 12174704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.